Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanak Raina

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Chemical Biology|June 13, 2017
Targeted protein knockdown using small molecule degradersKanak Raina, Craig M Crews
The Journal of Biological Chemistry|February 12, 2010
Chemical inducers of targeted protein degradationKanak Raina, Craig M Crews
Nature Chemical Biology|September 23, 2014
Targeted protein destabilization reveals an estrogen-mediated ER stress responseKanak Raina, Devin J Noblin, Yevgeniy V Serebrenik, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2012
Identification of hydrophobic tags for the degradation of stabilized proteinsHyun Seop Tae, Thomas B Sundberg, Taavi K Neklesa, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
Chemistry & Biology|June 9, 2015
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4Jing Lu, Yimin Qian, Martha Altieri, et al.
Nature Chemical Biology|July 5, 2011
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteinsTaavi K Neklesa, Hyun Seop Tae, Ashley R Schneekloth, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancerKanak Raina, Jing Lu, Yimin Qian, et al.
Journal of Medicinal Chemistry|July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
Blood|April 27, 2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Chemical Biology|June 13, 2017
Targeted protein knockdown using small molecule degradersKanak Raina, Craig M Crews
The Journal of Biological Chemistry|February 12, 2010
Chemical inducers of targeted protein degradationKanak Raina, Craig M Crews
Nature Chemical Biology|September 23, 2014
Targeted protein destabilization reveals an estrogen-mediated ER stress responseKanak Raina, Devin J Noblin, Yevgeniy V Serebrenik, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2012
Identification of hydrophobic tags for the degradation of stabilized proteinsHyun Seop Tae, Thomas B Sundberg, Taavi K Neklesa, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
Chemistry & Biology|June 9, 2015
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4Jing Lu, Yimin Qian, Martha Altieri, et al.
Nature Chemical Biology|July 5, 2011
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteinsTaavi K Neklesa, Hyun Seop Tae, Ashley R Schneekloth, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancerKanak Raina, Jing Lu, Yimin Qian, et al.
Journal of Medicinal Chemistry|July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
Blood|April 27, 2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 2